-

IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer

Vroemen—currently VP of R&D, Health & Biosciences— brings a track record of R&D leadership and commercial success to IFF’s Executive Leadership Team

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announces that Dr. Gregory Yep, Chief R&D and Sustainability Officer, has resigned effective Sept. 1 to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen—Vice President of R&D, Health & Biosciences—who has dedicated his career to the advancement and commercialization of leading-edge biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s Executive Leadership Team.

“Through Greg’s leadership, we have established IFF as the go-to partner for science-backed solutions for the health, fragrance, nutrition and home and personal care markets,” said Frank Clyburn, IFF CEO. “We thank Greg for his many contributions, and wish him well in his future endeavors. We have a strong successor in Casper, who will continue to advance our innovation pipeline and sustainability efforts.”

Vroemen joined the Company in 2004 as a scientist and project leader. Over the past two decades, he has assumed roles of increasing responsibility in research and development in Europe and the U.S., and has played a major role in establishing IFF as a bioscience powerhouse. During his tenure, he oversaw the company’s leading position in the protein engineering of industrial enzymes, contributed to the commercialization of multiple new technological advancements, and is a prolific inventor named on many patents.

As Chief R&D and Sustainability Officer, Vroemen will further IFF’s efforts in innovation, leading the company’s global R&D strategy, technological development, innovation pipeline and external collaborations. Vroemen holds a Master’s of Science in Molecular Life Sciences and a doctorate in Molecular Biology, both from Wageningen University in the Netherlands.

Welcome to IFF

At IFF (NYSE: IFF)—an industry leader in food, beverage, scent, health and biosciences—science and creativity meet to create essential solutions for a better world. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.

© 2023 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Media Relations:
Paula Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Media Relations:
Paula Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

More News From IFF

IFF Opens Vanilla Innovation Center in Madagascar

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health & bioscience—today announced the opening of its Vanilla Innovation Center in Madagascar, reinforcing vanilla as a strategic and priority tonality for IFF and strengthening its ability to innovate at origin. “The opening of the center marks an important step in how we approach vanilla innovation,” said Adam Jańczuk, Ph.D., senior vice president, research, creation and design, Taste, IF...

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

GRASSE, France--(BUSINESS WIRE)--LMR Naturals by IFF — a global leader in natural ingredients for perfumery, cosmetics and flavors — will debut its latest innovations at the International Exhibition of Raw Materials for Perfumery (SIMPPAR), May 26–27 in Grasse. During the industry event, IFF will unveil new additions to its LMR Hearts collection, highlighting its naturals expertise and pioneering science. “Responsible innovation has always been central to LMR,” said Bertrand de Préville, genera...

IFF Reports First Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.7 B   $209 M   $0.66   $568 M   20.7%   $1.25 Management Commentary “IFF is off to a solid start in 2026, with first quarter results that reflect the customer focus and operational execution we’ve been...
Back to Newsroom